Fludeoxyglucose 18F Radionuclide Injection
Market
Fludeoxyglucose 18F Radionuclide Injection Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Fludeoxyglucose 18F Radionuclide Injection Market
Size and Growth
The Fludeoxyglucose 18F Radionuclide Injection market research reports indicate a growing demand for this imaging agent due to its effectiveness in diagnosing various diseases. The market size for Fludeoxyglucose 18F Radionuclide Injection is estimated to be increasing steadily, driven by advancements in medical imaging technology and the rising prevalence of chronic diseases.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Zevacor Pharma
◍ Queen's PET Imaging
◍ Triad Isotopes
◍ NCM USA Bronx
◍ Spectron MRC
◍ Petnet Solutions
◍ Shertech Laboratories
◍ Precision Nuclear
The competitive landscape of the Fludeoxyglucose 18F Radionuclide Injection market includes companies like Zevacor Pharma, Queen's PET Imaging, Triad Isotopes, NCM USA Bronx, Spectron MRC, Petnet Solutions, Shertech Laboratories, and Precision Nuclear. These companies utilize Fludeoxyglucose 18F Radionuclide Injection in various medical imaging applications, helping to drive market growth.
- Zevacor Pharma: $150 million
- Queen's PET Imaging: $120 million
- Triad Isotopes: $180 million
Request Sample Report
Market Segmentation
By Application
Hospitals
Clinics
Diagnostics Center
Request Sample Report
By Product
◍ Sterile ◍ Non-sterile ◍
◍
◍
Market Growth
Request Sample Report
$ 3.10 Billion
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients